Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inosine monophosphate dehydrogenase 1 pseudogene 10 (IMPDH1P10) is classified as a pseudogene in Homo sapiens, meaning it is a genomic DNA sequence similar to the functional gene for inosine monophosphate dehydrogenase 1 (IMPDH1), but it is nonfunctional due to the absence of protein-coding ability[5][1][6]. Pseudogenes such as IMPDH1P10 generally do not produce functional proteins and are not typically involved in established biological processes or diseases, although some pseudogenes elsewhere in the genome have rare regulatory roles[3]. IMPDH1P10 is not considered a therapeutic target, does not encode an active enzyme, and has no known associated drugs or clinical biomarkers. Since it is a pseudogene, its inclusion or listing as a drug target or active receptor would be a misclassification[1][5][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inosine monophosphate dehydrogenase 1 pseudogene 10 (IMPDH1P10).